ImmunoPrecise Antibodies's market cap is currently ―. The company's EPS TTM is $-0.751; its P/E ratio is ―; ImmunoPrecise Antibodies is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Oct 24	Jul 24	Apr 24	Jan 24	Oct 23
Income Statement	-
Total Revenue	$ 6.13M	$ 5.26M	$ 6.46M	$ 6.22M	$ 6.15M
Gross Profit	$ 3.44M	$ 2.36M	$ 3.11M	$ 3.20M	$ 2.95M
EBIT	$ -2.94M	$ -4.63M	$ -18.83M	$ -3.46M	$ -2.59M
EBITDA	$ -1.53M	$ -3.23M	$ -17.25M	$ -2.15M	$ -1.24M
Net Income Common Stockholders	$ -2.55M	$ -4.00M	$ -18.05M	$ -2.94M	$ -2.62M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.53M	$ 3.91M	$ 3.46M	$ 6.20M	$ 6.02M
Total Assets	$ 59.96M	$ 59.30M	$ 59.94M	$ 78.69M	$ 75.61M
Total Debt	$ 13.33M	$ 13.50M	$ 13.68M	$ 14.39M	$ 9.57M
Net Debt	$ 9.80M	$ 9.59M	$ 10.22M	$ 8.19M	$ 3.56M
Total Liabilities	$ 27.29M	$ 26.45M	$ 26.07M	$ 28.87M	$ 23.58M
Stockholders Equity	$ 32.68M	$ 32.85M	$ 33.92M	$ 49.82M	$ 52.03M
Cash Flow	-
Free Cash Flow	$ -2.31M	$ -2.09M	$ -3.77M	$ -501.00K	$ -534.00K
Operating Cash Flow	$ -2.24M	$ -1.82M	$ -2.64M	$ -666.00K	$ -235.00K
Investing Cash Flow	$ -65.00K	$ -263.00K	$ -1.11M	$ 57.00K	$ -312.00K
Financing Cash Flow	$ 2.07M	$ 2.70M	$ 1.12M	$ 613.00K	$ -310.00K

Currency in USD

ImmunoPrecise Antibodies Earnings and Revenue History

Income Statement >

ImmunoPrecise Antibodies Debt to Assets

Balance Sheet >

ImmunoPrecise Antibodies Cash Flow

Cash Flow >

ImmunoPrecise Antibodies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing